Hepatitis A, B, and C Prevention Programs
Information and Programs for Adults and Adolescents at Risk
  Hep Express archives

Prevention Programs

  APIA programs
  Corrections, adult
  Corrections, juvenile
  Family planning
  Harm reduction
  Homeless programs
  Perinatal related
  School programs
  Other programs
  Index of programs
    Support Group Info
  Hepatitis B
  Hepatitis C
  Listed by state
    Hepatitis B Info
  FAQ about hep B
  Laws and mandates
  Case histories
    Hepatitis A Info
  FAQ about hep A
  Laws and mandates
  Case histories
    Hep-related Topics
  International adoption
  Tattooing and piercing
  Travel vaccination
  Healthcare workers
  Needle safety
    Other Information
  CDC website
  Hep organizations
  NASTAD website
  Contact NASTAD
  About NASTAD
  Privacy policy

(click on the image)

Adult corrections facilities

New York State Hepatitis C Continuity Program
Program name: New York State Hepatitis C Continuity Program
Population served: New York State Department of Correctional Services (NYSDOCS) inmates with hepatitis C who are undergoing treatment
Eligibility: DOCS inmates who are under treatment for hepatitis C and might not be able to complete their treatment due to length of their incarceration
Region served: New York State
Funding: None (staff is "in-kind")
Program started: October 2004 was start-up - program began 2005-5006
Number of clients: 75 since 2006

Colleen Flanigan, RN, MS
Viral Hepatitis Coordinator
AIDS Institute
New York State Department of Health
Corning Tower, Room 429
Empire State Plaza
Albany, NY 12237-0678
Phone: (518) 486-6808
Fax: (518) 474-2749
Email: Caf03@health.state.ny.us

Website: www.health.state.ny.us/diseases/aids/

IAC is not responsible for content found on other websites.

The Hepatitis C Continuity Program is a program for NYSDOCS inmates who are under treatment for hepatitis C. The program promotes treatment completion by collaborating with the DOCS, NYSDOH, NYS Division of Parole, NYC Health and Hospitals Corporation and other community based healthcare providers. The program involves multiple pre-release activities that involve the DOCS which identifies inmates who might not be able to complete their hepatitis C treatment due to length of their incarceration, DOCS also verifies geographic areas for release, coordinates pre-release plans with the parole officers, meets with the inmates to explain options of continuity and provides guidance with necessary enrollment paperwork. DOCS also ensure enough medications (Ribavirin) are supplied to releasees upon discharge and arranges for shipment of a two-week supply of the other treatment medication (PEG Interferon) to receiving healthcare providers, while Medicaid or other coverage is being arranged. There are also connections made with the community-based healthcare provider to confirm completion of paperwork to establish Medicaid eligibility if applicable, to make medical appointments, to inform appropriate medical staff regarding the administration of the medications and to collaborate with the community parole officer to contact the patient if an initial appointment is missed. Parole officers play an important role in encouraging releasees to keep appointments and in assessing for any supportive services.

There are challenges with this program that include lack of staff and releasee knowledge about hepatitis C, changing release dates, lack of medical providers willing to provide care to releasees, missed appointments and difficulties with reinstating Medicaid. There is, however, monitoring and evaluation in place to identify problems and to evaluate progress. Future plans include implementing protocols and new forms, a statewide video conference with DOCS and the parole staff, recruitment of additional providers and partnering with New York City DOH.

          Hepatitis Prevention Programs

444 North Capitol Street, NW Suite 339 Washington D.C. 20001 (202) 434-8090